Showing 121 - 140 of 280 results
ANSTO recently hosted a public Ask Us Anything event on nuclear medicine, sharing information on how we safely manufacture and distribute nuclear medicine across Australia each week to hundreds of hospitals and clinics.
Excellent radiolabelling facilities and the operation of OPAL, a world-class multi-purpose nuclear reactor, enable ANSTO to produce a large range of radioisotopes for Australian researchers in both radiopharmaceutical and environmental areas.
Michael Druce has been awarded a Public Service Medal in the Australia Day honours for his contribution to nuclear medicine production.
Consultant appointed to consider a variety of financial, manufacture and import options.
ANSTO recently re-started the OPAL Reactor after a six-month shutdown for essential maintenance and the installation of an upgraded facility.
This month ANSTO is opening its doors to 11 talented young people from across Australia as the two-year Graduate Program kickstarts.
A site for the National Radioactive Waste Management Facility has been acquired, with the new facility to be built near the town of Kimba on the South Australian Eyre Peninsula.
Swinburne University of Technology is launching an Australian-first Aerostructures Innovation Research Hub (AIR Hub) with the support of $12 million in funding from the Victorian Government.
Participants undertook IAEA training hosted by Macquarie University and ANSTO on use of radionuclides for soil and water investigations.
Update on Nuclear medicine production at ANSTO.
Collaboration investigates a promising new nanoparticle for potential use in combination with other therapies for brain cancer
Health researchers at ANSTO use world-class nuclear and isotopic techniques to undertake research and development activities to address some of the most challenging health problems.